September 2021

Antibody Characterization by Mass Spectrometry

2021-10-05T08:03:18-04:00September 28th, 2021|Webinars|

Abstract In this on-demand webinar, we discuss why it is important to characterize antibodies based on their physical properties not just by what they bind, and how you can easily do the former via mass spectrometry-based protein sequencing. Key Takeaways Antibodies are generally characterized based on what they bind, not their [...]

Overcoming Irreproducibility in Life Science Research

2021-10-04T16:40:15-04:00September 28th, 2021|Webinars|

Overcoming Irreproducibility in Life Science Research Sponsored by: Rapid Novor, Inc & Absolute Antibody Our team, along with four other industry panelists, discuss ways to safeguard their research through recombinant antibodies, cell culturing procedures, antibody protein sequences, and reference identifiers. Full Webinar Panelists: Andrew Bradbury, CSO at Specifica “Drug-Like Antibodies from [...]

August 2021

Antibody Validation and its Use Cases

2021-10-12T13:14:50-04:00August 4th, 2021|Articles|

Antibodies are used in a variety of ways in academia and industry, from tools to therapeutics. Because antibodies are produced using live processes, which are naturally error-prone, validation is required from time to time. Furthermore, to develop biological therapeutics, the protein sequence must be confirmed as part of the regulatory process.

July 2021

Why Verifying the Protein Sequence Is Crucial for Antibody Validation

2021-10-04T15:29:50-04:00July 23rd, 2021|Articles|

Written by María Gerpe, PhD July 23, 2021 Why the Amino Acid Sequence Matters As proteins are assembled, they fold into different structural orders: from primary to quaternary. The exact sequence of the primary structure (the amino acid sequence) will dictate how a protein will fold and therefore function. The importance [...]

June 2021

Major Antibody Databases and Their Applications

2021-10-05T08:24:12-04:00June 18th, 2021|Articles|

Written by María Gerpe, PhD June 18, 2021 Introduction Research publications represent an additional source of validation proof for commercially available antibodies. As such, academic and industry scientists often also rely on publication references to decide which commercial antibody to purchase. Several independent efforts exist to compile such information. For instance, [...]

March 2021

October 2020

Research Insurance with de novo Protein Sequencing

2021-10-04T16:37:54-04:00October 26th, 2020|Webinars|

Research Insurance with de novo Protein Sequencing Originally presented October 16, 2020 by Monique Seymour, International Scientific Sales Executive, Rapid Novor If you could have guaranteed stability, certainty, and reproducibility for your research, would you be interested? Imagine this, if you're 2 years into your project and your freezer died along [...]

June 2016

Moving Towards Recombinant Monoclonal Antibodies

2021-10-15T09:36:33-04:00June 30th, 2016|Articles|

Recombinant Monoclonal Antibodies (rAbs) are highly reproducible, customizable and pure alternatives to the traditional antibodies produced by hybridomas. Get the antibody protein sequence, either by DNA sequencing or the de novo protein sequencing technology, you can rest assured that you can have the exact antibody made recombinantly anytime in the future.